153 related articles for article (PubMed ID: 28934848)
21. Plasma and serum exosome markers analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry coupled with electron multiplier.
Shan L; Gao H; Zhang J; Li W; Su Y; Guo Y
Talanta; 2022 Sep; 247():123560. PubMed ID: 35623246
[TBL] [Abstract][Full Text] [Related]
22. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Zheng N; Pan C; Liu W
J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
[TBL] [Abstract][Full Text] [Related]
23. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
Pallua JD; Schaefer G; Seifarth C; Becker M; Meding S; Rauser S; Walch A; Handler M; Netzer M; Popovscaia M; Osl M; Baumgartner C; Lindner H; Kremser L; Sarg B; Bartsch G; Huck CW; Bonn GK; Klocker H
J Proteomics; 2013 Oct; 91():500-14. PubMed ID: 23954705
[TBL] [Abstract][Full Text] [Related]
24. Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.
Huang TL; Cho YT; Su H; Shiea J
Clin Chim Acta; 2013 Sep; 424():175-81. PubMed ID: 23778025
[TBL] [Abstract][Full Text] [Related]
25. Identifying serum biomarkers for ovarian cancer by screening with surface-enhanced laser desorption/ionization mass spectrometry and the artificial neural network.
Yang J; Zhu Y; Guo H; Wang X; Gao R; Zhang L; Zhao Y; Zhang X
Int J Gynecol Cancer; 2013 May; 23(4):667-72. PubMed ID: 23574802
[TBL] [Abstract][Full Text] [Related]
26. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
[TBL] [Abstract][Full Text] [Related]
27. The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
Longuespée R; Boyon C; Castellier C; Jacquet A; Desmons A; Kerdraon O; Vinatier D; Fournier I; Day R; Salzet M
Histochem Cell Biol; 2012 Jul; 138(1):141-54. PubMed ID: 22532226
[TBL] [Abstract][Full Text] [Related]
28. Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.
Boccardo F; Rubagotti A; Nuzzo PV; Argellati F; Savarino G; Romano P; Damonte G; Rocco M; Profumo A
Int J Cancer; 2015 Nov; 137(10):2394-402. PubMed ID: 25994113
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
[TBL] [Abstract][Full Text] [Related]
30. A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.
Lopez MF; Mikulskis A; Kuzdzal S; Golenko E; Petricoin EF; Liotta LA; Patton WF; Whiteley GR; Rosenblatt K; Gurnani P; Nandi A; Neill S; Cullen S; O'Gorman M; Sarracino D; Lynch C; Johnson A; Mckenzie W; Fishman D
Clin Chem; 2007 Jun; 53(6):1067-74. PubMed ID: 17463175
[TBL] [Abstract][Full Text] [Related]
31. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
[TBL] [Abstract][Full Text] [Related]
32. Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer.
Roh K; Yeo SG; Yoo BC; Kim KH; Kim SY; Kim MJ
Anticancer Drugs; 2016 Sep; 27(8):787-93. PubMed ID: 27272410
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
34. Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling.
Yoo BC; Kong SY; Jang SG; Kim KH; Ahn SA; Park WS; Park S; Yun T; Eom HS
BMC Cancer; 2010 Feb; 10():55. PubMed ID: 20175931
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages.
de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
[TBL] [Abstract][Full Text] [Related]
37. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
[No Abstract] [Full Text] [Related]
38. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
39. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
[TBL] [Abstract][Full Text] [Related]
40. A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.
Benkali K; Marquet P; RĂ©rolle J; Le Meur Y; Gastinel L
BMC Genomics; 2008 Nov; 9():541. PubMed ID: 19014585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]